Abstracting and Indexing

  • PubMed NLM
  • Google Scholar
  • Semantic Scholar
  • Scilit
  • CrossRef
  • WorldCat
  • ResearchGate
  • Academic Keys
  • DRJI
  • Microsoft Academic
  • Academia.edu
  • OpenAIRE
  • Scribd
  • Baidu Scholar

Giant Cell-Rich Osteosarcoma (GCRO) of the Spine on T6 and T7 Vertebral Mass Case Report Literature Review

Article Information

Sayed Abdulla jami, Shi Jiandang*, Sohel Tanvir MM, Zhanwen Zhou

Department of Spinal Surgery, General Hospital of Ningxia Medical University, Ningxia Medical University,   Ningxia, People’s Republic of China

*Corresponding Author: Shi Jiandang, Department of Spinal Surgery, General Hospital of Ningxia Medical University, Ningxia Medical University 804 Shengli Street, Xingqing District, Yinchuan, 750004, Ningxia, People’s Republic of China.

Received: 16 December 2019; Accepted: 20 December 2019; Published: 30 June 2020

Citation: Sayed Abdulla jami, Shi Jiandang, Sohel Tanvir MM, Zhanwen Zhou. Giant cell-rich osteosarcoma (GCRO) of the spine on T6 and T7 vertebral mass case report literature review. Journal of Orthopaedics and Sports Medicine 2 (2020): 140-146.

View / Download Pdf Share at Facebook

Abstract

Giant cell-rich osteosarcoma (GCRO) is a rare type of osteosarcoma, which is easily misdiagnosed as the bone size on imaging and histology of cell tumors, and GCRO in the spine is exceptionally rare. A case of GCRO confirmed by surgical pathology in our hospital is reported. 45 years old female patient with GCRO on T6 and T7 vertebra performed a surgical procedure. This study's purpose was to review the clinical presentation, imaging, pathology, and outcome of patients with giant cell-rich osteosarcoma (GCRO) of bones. A total of 18 patient’s data with our GCRO case were analyzed for this review literature.

Keywords

Osteosarcoma; GCRO; Spine; Case; Review

Osteosarcoma articles Osteosarcoma Research articles Osteosarcoma review articles Osteosarcoma PubMed articles Osteosarcoma PubMed Central articles Osteosarcoma 2023 articles Osteosarcoma 2024 articles Osteosarcoma Scopus articles Osteosarcoma impact factor journals Osteosarcoma Scopus journals Osteosarcoma PubMed journals Osteosarcoma medical journals Osteosarcoma free journals Osteosarcoma best journals Osteosarcoma top journals Osteosarcoma free medical journals Osteosarcoma famous journals Osteosarcoma Google Scholar indexed journals Giant cell-rich articles Giant cell-rich Research articles Giant cell-rich review articles Giant cell-rich PubMed articles Giant cell-rich PubMed Central articles Giant cell-rich 2023 articles Giant cell-rich 2024 articles Giant cell-rich Scopus articles Giant cell-rich impact factor journals Giant cell-rich Scopus journals Giant cell-rich PubMed journals Giant cell-rich medical journals Giant cell-rich free journals Giant cell-rich best journals Giant cell-rich top journals Giant cell-rich free medical journals Giant cell-rich famous journals Giant cell-rich Google Scholar indexed journals Spine articles Spine Research articles Spine review articles Spine PubMed articles Spine PubMed Central articles Spine 2023 articles Spine 2024 articles Spine Scopus articles Spine impact factor journals Spine Scopus journals Spine PubMed journals Spine medical journals Spine free journals Spine best journals Spine top journals Spine free medical journals Spine famous journals Spine Google Scholar indexed journals Lower back pain articles Lower back pain Research articles Lower back pain review articles Lower back pain PubMed articles Lower back pain PubMed Central articles Lower back pain 2023 articles Lower back pain 2024 articles Lower back pain Scopus articles Lower back pain impact factor journals Lower back pain Scopus journals Lower back pain PubMed journals Lower back pain medical journals Lower back pain free journals Lower back pain best journals Lower back pain top journals Lower back pain free medical journals Lower back pain famous journals Lower back pain Google Scholar indexed journals Trauma articles Trauma Research articles Trauma review articles Trauma PubMed articles Trauma PubMed Central articles Trauma 2023 articles Trauma 2024 articles Trauma Scopus articles Trauma impact factor journals Trauma Scopus journals Trauma PubMed journals Trauma medical journals Trauma free journals Trauma best journals Trauma top journals Trauma free medical journals Trauma famous journals Trauma Google Scholar indexed journals T6 spines articles T6 spines Research articles T6 spines review articles T6 spines PubMed articles T6 spines PubMed Central articles T6 spines 2023 articles T6 spines 2024 articles T6 spines Scopus articles T6 spines impact factor journals T6 spines Scopus journals T6 spines PubMed journals T6 spines medical journals T6 spines free journals T6 spines best journals T6 spines top journals T6 spines free medical journals T6 spines famous journals T6 spines Google Scholar indexed journals Thoracolumbar articles Thoracolumbar Research articles Thoracolumbar review articles Thoracolumbar PubMed articles Thoracolumbar PubMed Central articles Thoracolumbar 2023 articles Thoracolumbar 2024 articles Thoracolumbar Scopus articles Thoracolumbar impact factor journals Thoracolumbar Scopus journals Thoracolumbar PubMed journals Thoracolumbar medical journals Thoracolumbar free journals Thoracolumbar best journals Thoracolumbar top journals Thoracolumbar free medical journals Thoracolumbar famous journals Thoracolumbar Google Scholar indexed journals Pedicle articles Pedicle Research articles Pedicle review articles Pedicle PubMed articles Pedicle PubMed Central articles Pedicle 2023 articles Pedicle 2024 articles Pedicle Scopus articles Pedicle impact factor journals Pedicle Scopus journals Pedicle PubMed journals Pedicle medical journals Pedicle free journals Pedicle best journals Pedicle top journals Pedicle free medical journals Pedicle famous journals Pedicle Google Scholar indexed journals Bone tumors articles Bone tumors Research articles Bone tumors review articles Bone tumors PubMed articles Bone tumors PubMed Central articles Bone tumors 2023 articles Bone tumors 2024 articles Bone tumors Scopus articles Bone tumors impact factor journals Bone tumors Scopus journals Bone tumors PubMed journals Bone tumors medical journals Bone tumors free journals Bone tumors best journals Bone tumors top journals Bone tumors free medical journals Bone tumors famous journals Bone tumors Google Scholar indexed journals Chondrosarcoma articles Chondrosarcoma Research articles Chondrosarcoma review articles Chondrosarcoma PubMed articles Chondrosarcoma PubMed Central articles Chondrosarcoma 2023 articles Chondrosarcoma 2024 articles Chondrosarcoma Scopus articles Chondrosarcoma impact factor journals Chondrosarcoma Scopus journals Chondrosarcoma PubMed journals Chondrosarcoma medical journals Chondrosarcoma free journals Chondrosarcoma best journals Chondrosarcoma top journals Chondrosarcoma free medical journals Chondrosarcoma famous journals Chondrosarcoma Google Scholar indexed journals Pathological fracture articles Pathological fracture Research articles Pathological fracture review articles Pathological fracture PubMed articles Pathological fracture PubMed Central articles Pathological fracture 2023 articles Pathological fracture 2024 articles Pathological fracture Scopus articles Pathological fracture impact factor journals Pathological fracture Scopus journals Pathological fracture PubMed journals Pathological fracture medical journals Pathological fracture free journals Pathological fracture best journals Pathological fracture top journals Pathological fracture free medical journals Pathological fracture famous journals Pathological fracture Google Scholar indexed journals Bone destruction articles Bone destruction Research articles Bone destruction review articles Bone destruction PubMed articles Bone destruction PubMed Central articles Bone destruction 2023 articles Bone destruction 2024 articles Bone destruction Scopus articles Bone destruction impact factor journals Bone destruction Scopus journals Bone destruction PubMed journals Bone destruction medical journals Bone destruction free journals Bone destruction best journals Bone destruction top journals Bone destruction free medical journals Bone destruction famous journals Bone destruction Google Scholar indexed journals Malignant cells articles Malignant cells Research articles Malignant cells review articles Malignant cells PubMed articles Malignant cells PubMed Central articles Malignant cells 2023 articles Malignant cells 2024 articles Malignant cells Scopus articles Malignant cells impact factor journals Malignant cells Scopus journals Malignant cells PubMed journals Malignant cells medical journals Malignant cells free journals Malignant cells best journals Malignant cells top journals Malignant cells free medical journals Malignant cells famous journals Malignant cells Google Scholar indexed journals Sarcomatous stroma articles Sarcomatous stroma Research articles Sarcomatous stroma review articles Sarcomatous stroma PubMed articles Sarcomatous stroma PubMed Central articles Sarcomatous stroma 2023 articles Sarcomatous stroma 2024 articles Sarcomatous stroma Scopus articles Sarcomatous stroma impact factor journals Sarcomatous stroma Scopus journals Sarcomatous stroma PubMed journals Sarcomatous stroma medical journals Sarcomatous stroma free journals Sarcomatous stroma best journals Sarcomatous stroma top journals Sarcomatous stroma free medical journals Sarcomatous stroma famous journals Sarcomatous stroma Google Scholar indexed journals

Article Details

1. Introduction

Osteosarcoma (OS) is the most common primary malignant tumor of bone and in which neoplastic cells produce osteoid [1]. GCRO multinucleated giant cells are so obvious that these cells cover up the heteromorphic tumor cells of OS, and histological images of many uniformly distributed multinucleated osteoclast-like giant cells are similar to giant cell tumor of bone [2]. GCRO is usually misdiagnosed as a giant cell tumor of bone, as they have similar radiological and pathological features, which have seldom been reported in the literature [3-8]. Microscopic examination reveals that direct formation of the osteoid by the malignant cells is not seen in malignant giant cell tumors, and the location of giant cell tumors is present in addition to verified areas of sarcomatous stroma [9]. This may be the key factor in differentiating these two lesion types.

2. Case Presentation

45 years old female, 2017 February, because of the waist pain, swelling, after rest can be relieved she was admitted to hospital for aggravation of her lower back pain months ago; and had no history of trauma.

2.1 Physical examinations

Patient placed in supine position, physiological bending of the column on spine was found, and there was tenderness in T6 spines, while there was no palpable tenderness or knocking at other spines vertebra pain; No obvious hypoesthesia, double lower limbs muscle ? level, the straight leg raising test, and strength test negative, femoral nerve test negative, heel hip test negative, "4" word test was done.

2.2 Imaging examination

CT was combined like consider pathological compression fracture of the T6 vertebral body with spinal compression, T6, and T7 bone mass destruction. (Figure 1) Surgical procedures: Titanium mesh was removed, and pedicle screws were reconstructed via posterior T6 and T7 vertebral bodies, internal fixation of the rod system, intraoperative T6, T7 vertebral body subcutaneous filled with fish-like tumors lesions, rich blood vessels, lamina, pedicle have tumor lesions invasion.

2.3 Disease diagnosed

Giant cell-rich osteosarcoma (Figure 1).

fortune-biomass-feedstock

Figure 1: (a) View of the CT scan- An osteolytic lesion is seen with cortical destruction affecting the T6 vertebra; (b) The first biopsy specimens show a solid proliferation of atypical mononuclear stromal cells with osteoclast-like giant cells; (c) Showing mild nuclear atypia and pleomorphism. Intervening lace-like osteoid deposits and multinucleated osteoclast-like giant cells; (d) Fish analysis for MDM2 amplification revealed numerous red signals which labelled the MDM2 locus in chromosome 12q15; (e) MDM2 Positive nuclear immune reactivity; (f) Negative immune staining for H3.3 G34W.

3. Materials and Methods

Formal review of all published literature from the last 30 years related to GCRO types in internet-based journals and PubMed Was performed to optimize and capture all relevant studies. Pathologically confirmed GCRO were retrospectively reviewed with specific imaging findings, age, sex, eccentricity, ossification, lysis, cystic change, expansile growth, periosteal reaction, outcome, symptoms, follow-up, cortical destruction, soft tissue extension, and joint involvement were documented.

4. Discussion

Giant cell-rich osteosarcoma is a rare type of OS, radiographic and histologically is easy to be misdiagnosed as a giant cell tumor of bone. Haslan et al. [10] calculated that the OS of the spine only accounted for the primarily 4%. Bathurst et al. [2] reported that a GCRO account for approximately all OS is 3%, but GCRO of the spine is extremely rare. OS mainly occurs in the metaphyseal and diaphysis of the long bone of the four limbs are more common in distal femur, and proximal tibia highest incidence was from 10 to 25 years old, and over 50 years old the incidence of tumors is higher in men than in women, while the ratio of primary spinal OS is approximately 1?1, the average age is slightly older, typical in the thoracolumbar spine, but also found in the cervical and sacral spine vertebra. Haslan et al. [10] collected 198 cases of primary spinal OS, including 95 cases of male and 95 cases of female, there were 103 cases of ranging in age from 8 to 80 years, with an average age of 34.5 years; There were 66 cases (33.3%) of thoracic vertebra, 64 cases (32.3%) of lumbar vertebra and 41 cases of sacral vertebra (20.7%). Schoenfeld et al. [11] collected the diagnosis of Massachusetts general hospital from 1982 to 2008 primary osteosarcoma of the spine was reported in 26 patients, including 15 males and 11 females, age 5 - 82, with an average age of 46; there were 3 cases of cervical vertebra, 6 cases of thoracic vertebra, 9 cases of lumbar vertebra and 8 cases of sacral vertebra Cases. High-risk T6 and T7 vertebral bodies are common sites of OS of the spine. Primary spinal bone sarcomas are common in the vertebral body and can affect the vertebral body alone or the pedicle and appendages. When a typical mass or "brush" tumor appears in the spinal lesion, the bone and flesh are highly considered as a tumor. Bone tumors are seen in the soft tissue near the vertebrae, especially in young peoples, and this shows that OS is possible; Compared with other benign and malignant vertebral tumors, OS often involves continuous multiple vertebral bodies [12]. The imaging shows of GCRO are similar to those of giant cell tumor of bone [6], bone destruction, soapy, osteoblastic bone destruction is rare, no fracture of bone cortex, easy to misdiagnose. Literature reports that GCRO occurs in femoral bones of young patients in the metaphyseal region of the trunk and tibia, the main imaging manifestations were lytic bone destruction, and bone destruction margin of the area is fuzzy, usually without soft tissue mass, and the periosteum reaction is not apparent [3]. Sato et al. [13] believed that the GCRO of long bone was mainly manifested as lytic bone destruction, swelling change, and bone cortical thinning, with no obvious damage. Some cases have been reported [14] in the maxillary bone GCRO, presented as an expansive heterogeneous mass with extensive destruction of the cortical bone, is intraluminal, this is a speckled calcification, misdiagnosed as chondrosarcoma. Swelling of one or more vertebrae and pedicle leads to osteolytic destruction of bone quality is rough and discontinuous, the inner edge sees the thick bone crest, the edge does not see the sclerosis edge, does not have the periosteum to reverse should be. OS of the spine does not typically have layered or scallion skin periosteum reaction and the Codman triangle makes differential diagnosis difficult.

Author

Age/

sex

Symptoms

Location

Radiological findings

Recurrence and metastasis

Follow-up

Bathurst et al. [3]

           
 

41/F

Pain and palpable mass

Femur diaphysis

Expansile lytic lesion with ill-defined margins, the cortex is breached with a soft tissue mass

Local recurrence, lung

DWD, 3 years

 

13/M

Pain and palpable mass

Tibia diaphysis

Lytic lesion with periosteal reaction

None

NED, 16 years

 

21/M

Tender

Palpable mass

Femur diaphysis

Ill-defined, expansile lytic with periosteal reaction

Local recurrence

NED, 9 years

 

12/M

Ache, ununited fracture

Femur diaphysis

Expansile lytic with pathological fracture

Sacrum

DWD, 3 years

 

6/F

Pain and limping

Tibia metaphysis

Lytic, slightly expansile lesion with pathological fracture

None

NED, 7 years

 

16/F

Pain above knee

Femur diaphysis

Lytic, slightly expansile, ill-defined lesion with periosteal

Recurrence,

lung

DWD, 2 years

 

12/M

Palpable mass

Tibia metaphysis

Ill-defined, expansile lytic lesion

Recurrence,

lung

DWD, 2 years dysfunction

 

20/M

Pain in knee

Femur condyle

Ill-defined, expansile lytic lesion

None

NED, 2 years

 

8/M

Palpable mass in the thigh

Femur diaphysis

Mixed sclerotic and lytic lesion with Codman’s triangle, soft tissue mass, and pathological fracture

None

NED, 6 years

Sato et al. [13]

19/M

Motion pain

Femur metadiaphysis

Osteolytic lesion, cortical thinning and ballooning, onion skin-like periosteal reaction

Sacrum

DWD, 3 years

Bertoni et al. [4]

19/M

Fracture

Femur diaphysis

Osteolytic lesion with wide geographic margins, cortical destruction, soft tissue extension

Recurrence, multiple

DWD, 20 years

Shinozaki et al. [5]

17/M

Pain, palpable mass, local heat tenderness

Distal radius

Osteolytic lesion

Recurrence, multiple bone metastesis, lung

DWD, 41 months

Hong et al. [6]

29/F

Pain

Tibia metaphysis

Osteolytic lesion well-marginated mass with cortical destruction and small soft tissue

None

NED, 11 months

Nagata et al. [7]

32/M

Pain and palpable mass

Distal femur

Ill-defined, centric expansile lytic lesion with pathological fracture

None

NED, 20 Months

kinoshita et al. [8]

16/M

Pain

11th rib

Eccentric hemispherical osteolytic lesion with disappearance of the cortex, Codman’s triangle-like periosteal reaction

None

NED, 5 years

Fu et al. [2]

67/F

Progressive growth of painless mass

Mandible

Osteolytic lesion

None

NED, 1 years

Verma et al. [14]

56/F

Cheek palpable mass, nasal obstruction

Maxilla

Expansile, hyperdense soft tissue mass, areas of calcification within the substance of tumor with sclerosis

None

NED, unknown

Gambarotti et al[15]

29/M

Pain

Femur metaphysis

Osteolytic lesion

Recurrence

NED, unknown

Our case

45/F

Pain on waist and lower back, palpable mass, area heat

T6 and T7 vertebra

Pathological fracture, spine compression, bone destruction, fish-like tumor lesion

None

NED, 2 years

Table 1: Previously reported 18 cases of giant cell-rich osteosarcoma.

DWD, dead with disease; NED, no evidence of disease; M, male; F, female

In all reported cases (Table 1), including the cases in this study, 10 affected the femur, 4 the tibia, and others are the radius, rib, vertebra, mandible, and maxilla, respectively. A large number of cases reside in the femur and tibia, where other conventional OS and giant cell tumors are typically situated. Patients usually present non- specific clinical symptoms. The two most common chief complaints in these patients were pain (77.8%) and palpable mass (44.4%). However, the vast majority of GCROs are metaphyseal, whereas most giant cell tumors occur in the epiphysis. GCRO in these case reports showed a high recurrence nature, but our reported case is recurrence-free; 7 cases are a recurrence. GCRO should be differentiated from malignant giant cell tumor. Besides, GCRO often creates difficulty in making a diagnosis when tissue samples do not include osteoid [2, 8]. So according to comparison with other literature, authors suggest doing the surgical procedure and careful follow-up may decrease the recurrence rate of GCRO, but further study is needed to conduct about this rare tumor because only a few cases and clinical articles are published on vertebral GCRO. Thus, because of its rarity, the diagnosis of Giant cell-rich osteosarcoma (GCRO) is challenging.

5. Conclusion

The spine OS should be highly considered for the presence of typical lumpy, "brush" tumor bone in the lesion. It is challenging to differentiate spinal GCRO from spinal giant cell tumor, and pathological diagnosis is required. Our case study patient surgery was successfully done. After more than 24-months of follow-up, her tumor wasn't recurrence, but it is hard to ensure recurrence occurrence. However, the surgery not only remains a mainstay for GCRO treatment, so for this rare tumor, but the author also suggested more study is required, such as a multi-center study to provide more effective technique information for clinical diagnosis and treatment.

Acknowledgment

The authors would like to thank all who were participating in the study.

Conflicts of Interest

There are no conflicts of interest.

Ethical Approval

Hospital ethical committee and patient approved this manuscript for publication.

Source of Funding

Not applicable.

Abbreviations

Not applicable.

Authors’ Contributions

SAJ and SJ design the manuscript. ZZ and MMST conducted data collection and follow-up procedures. SJ gives instructions, and ZZ revises the manuscript; SAJ writes different parts, and MMST edits this manuscript; all authors approved the final manuscript.

Statement of Informed Consent

Research-informed consent was obtained from per institutional protocol.

Statement of Human and Animal Rights

The ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 and 2008 were followed accordingly.

References

  1. Jo VY, Fletcher CDM. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 46 (2014): 95-104.
  2. Fu HH, Zhuang QW, He J, et al. Giant cell-rich osteosarcoma or giant cell reparative granuloma of the mandible? J Craniofac Surg 22 (2011): 1136-1139.
  3. Bathurst N, Sanerkin N, Watt I. Osteoclast-rich osteosarcoma. British Journal of Radiology 59 (1986): 667-673.
  4. Bertoni F, Bacchini P, Staals EL. Giant cell-rich osteosarcoma. Orthopedics 26 (2003): 179- 181.
  5. Shinozaki T, Fukuda T, Watanabe H, et al. Giant cellrich osteosarcoma simulating giant cell tumor of bone. Kitakanto Med J 54 (2004): 147-151.
  6. Hong SJ, Kim KA, Yong HS, et al. Giant cell-rich osteosarcoma of bone. Eur J Radiol Extra 53 (2005): 87-90.
  7. Nagata S, Nishimura H, Uchida M, et al. Giant cell-rich osteosarcoma of the distal femur: radiographic and magnetic resonance imaging findings. Radiat Med 24 (2006): 228-232.
  8. Kinoshita G, Yasoshima H. Giant cell-rich tumor of the rib. J Orthop Sci 11 (2006): 312-317.
  9. Nascimento AG, Huvos AG, Marcove RC. Primary malignant giant cell tumor of bone: a study of eight cases and review of the literature. Cancer 44 (1979): 1393-1402.
  10. Ilaslan H, Sundaram M, Unni KK, et al. Primary Vertebral Osteosarcoma: Imaging Findings1. Radiology 230: 697-702.
  11. Schoenfeld AJ?Hornicek FJ?Pedlow FX?et al. Osteosarcoma of the spine?experience in 26 patients treated at the Massachusetts General Hospital [J]. Spine J 10 (2010): 708- 714.
  12. Lefebvre G, Renaud A, Rocourt N, et al. Primary vertebral osteosarcoma: Five cases. Joint Bone Spine Revue Du Rhumatisme 80: 534-537.
  13. Sato K, Yamamura S, Iwata H, et al. Giant Cell-Rich Osteosarcoma: A Case Report 59 (1996): 151.
  14. Verma RK, Gupta G, Bal A et al. Primary Giant Cell Rich Osteosarcoma of Maxilla: An Unusual Case Report. Journal of Maxillofacial & Oral Surgery 10: 159-162.
  15. Gambarotti M, Donato M, Alberghini M, et al. A strange giant cell tumor 77: 0-5.

Journal Statistics

Impact Factor: * 4.3

CiteScore: 2.9

Acceptance Rate: 73.64%

Time to first decision: 10.4 days

Time from article received to acceptance: 2-3 weeks

Discover More: Recent Articles

Grant Support Articles

© 2016-2024, Copyrights Fortune Journals. All Rights Reserved!